Greedy Insider · Filing
LONA · 13D amendment · Sermonix Pharmaceuticals, Inc. and affiliates
Sermonix Pharmaceuticals, Inc. and affiliates reported a 25.1% stake in LeonaBio, Inc. (LONA) in a Schedule 13D amendment filed on Oct 28, 2026, triggered by an event on Oct 26, 2026.
Describes filing structure, not future returns. Not investment advice.
Primary source: SEC EDGAR · Accession 0001655566-26-000004